You are here

Article info

Article menu
Download PDFPDF
Therapeutics
Systematic Review and meta-analysis
Tiotropium mist inhaler for COPD increases risk of mortality compared with placebo

Authors

  1. Correspondence to: Felix S F Ram
    School of Health and Social Sciences, Massey University, Private Bag 102–904, North Shore, Auckland 0630, New Zealand; fsfram{at}yahoo.co.uk
View Full Text

Citation

Ram FSF
Tiotropium mist inhaler for COPD increases risk of mortality compared with placebo
BMJ Evidence-Based Medicine 2011;16:189-190.

Publication history

  • First published September 21, 2011.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions